First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial
一线 FOLFIRI 联合贝伐单抗治疗根据血清 LDH 水平进行前瞻性分层的晚期结直肠癌患者:GISCAD(意大利消化道癌症研究组)CENTRAL(ColorEctalavastiNTRiAlLdh)试验的最终结果
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/bjc.2017.234
Giampieri, Riccardo; Puzzoni, Marco; Daniele, Bruno; Ferrari, Daris; Lonardi, Sara; Zaniboni, Alberto; Cavanna, Luigi; Rosati, Gerardo; Pella, Nicoletta; Zampino, Maria Giulia; Sozzi, Pietro; Germano, Domenico; Zagonel, Vittorina; Codecà, Carla; Libertini, Michela; Labianca, Roberto; Cascinu, Stefano; Scartozzi, Mario